Menu

Research Reports

Zee5 reported a net profit of Rs. 122 cr. 

Zee5 reported a net profit of Rs. 122 cr. 

Zee5 reported a net profit of Rs. 122 cr. 

Total revenue increased 4% year on year to Rs. 1846Cr.Ad revenue increased 5.4% year on year to Rs970 Cr, while subscription revenue decreased 5.1% year on year to Rs772 Cr. The EBITDA margin was at a multiyear low and declined by 31.5% YoY to Rs236Cr. with a margin of 12.8. The adjusted PAT declined by 45.3% YoY to Rs122 CR. with a margin of 6.6%. ZEE5 revenues declined by 1.1% QoQ to Rs.15 Cr., with global Monthly Average Users and Daily Active Users of 10 Cr. and 1 Cr., respectively. They also launched 38 new shows and movies in 1QFY23, which included 8 originals, and the EBITDA loss stood at Rs. 23Cr.

Current Quarter Operations:

The company launched 26 new shows on linear TV. The TRAI has revised the NTO 2.0 implementation timeline to November 2022. As of June 2022, the outstanding from Dish is Rs. 1900Cr. There are receivables of Rs 35 Cr. outstanding from Siti. In a stable macro environment, the loss of revenue on the withdrawal of Zee Anmol from FTA could be recouped within 1 year through 40% and 60% of subscription and advertisement revenues, respectively. ZEE5 has undertaken a price hike from Rs.499 to Rs.599 in March and then to Rs.699 in July. Around Rs. 25Cr. of the Rs. 37Cr. sequential increase in inventory is related to movies.The over-the-top (OTT) industry is anticipated to expand from Rs 2,590 crore in 2018 to Rs 11,944 crore by 2023, representing a compound annual growth rate of 36%.

The analysis warns that this could result in a recurrence of the 1980s VCR/VCP/DVD boom industry’s abrupt demise, given the exponential growth of multiplexes across metro and urban areas during the early 2000s. In a first-of-its-kind move, renowned OTT platform ZEE5 has collaborated with T-Hub. This is the first time that a streaming platform has joined forces with an innovation project for the promotion of a show. The ZEE5 team was at T-Hub to spread the word about their latest show, Hello World, recently.

Valuations:

The company has reported an EPS of Rs. 1.11 for the period ended June 30, 2022 as compared to Rs. 2.23 for the period ended June 30, 2021. The ROCE and ROE stood at 14.8% and 9.98%, respectively. The stock is trading at a P/E of 26.4x, which is not expensive, and a 5-year P/E of 24.4x. The EBITDA multiple is 13.5x and has an interest coverage ratio of 28.8x. The price to book ratio is at 2.27x, which has a book value of Rs.113. The scrip was trading at Rs.257, up by 2.25% on Tuesday.

Tips Industries generated a net profit of Rs. 17.17 cr. in Q1 FY23.

Tips Industries generated a net profit of Rs. 17.17 cr. in Q1 FY23.

Tips Industries generated a net profit of Rs. 17.17 cr. in Q1 FY23.

Tips Industries has reported a total income of Rs. 35.2626 crores during the period ended June 2022 as compared to Rs. 35.4814 crores during March 2022 and Rs. 28.7249 crores during June 2021. The company has posted a net profit of Rs. 17.1793 crores in June 2022 as against a net profit of Rs. 15.9260 crores for the period ended March 2022 and Rs. 15.6298 crores for the period ended June 2021. The operating margin stood at 66% compared to in Q1 FY22, which was lower than the 72% in Q1 FY22. The EBITDA margins were up by 600 bps in Q1 FY23 as against Q4 FY22.

Current quarter operations:

The company released 185 new songs and 142 non-film songs, with 43 film songs under their name. The company now has a collection of around 29,000. songs across all genres and major languages. The Indian digital advertising industry stood at Rs 21,353 crore by the end of 2021, up by Rs 15,782 crore in the previous year. It has grown at a rate of 35.3%. This sustained growth can be attributed to technological advancements, improvements in data science and analytics, and the introduction of policies and regulations, among others. The highest proportion of spending on digital media is claimed by social media (29%, Rs 6,218 crore), closely followed by online video (28%, Rs 5,907 crore).  Paid search claims 23% (Rs 5,039 crore), while display banners claim 16% (Rs 3,420 crore).

By 2023, social media is expected to grow at a CAGR of 29.79%, with a spending share of 29%. On an average, Indians spend 2-3 hours on social media, which is on par with the global average. 73% of the audience belonging to the age group of 45 years to 54 years uses YouTube to watch online content. The listenership on audio streaming services grew by 40% Y-o-Y in the first half of 2020.

 

Valuations:

The company has reported an EPS of Rs.13.25 for the period ended June 30, 2022 as compared to Rs.12.05 for the period ended June 30, 2021. The ROCE and ROE stood at 86.5% and 63%, respectively. The stock is trading at a P/E of 26.1x, which is not expensive, and a 5 year P/E of 28.5x. TIPS industries have an EBITDA multiple of 12.2x and an interest coverage ratio of 721x. The price to book ratio is at 19.2x, which has a book value of Rs.78.8. The scrip was trading at Rs. 1525, down by 1.34% on Monday.

Shipa Medicare reported an 85 lakh net profit.

Shilpa Medicare reported an 85 lakh net profit.

Shipa Medicare reported an 85 lakh net profit.

Shipa Medicare has reported a total income of Rs. 269.2583 crores during the period ended June 30, 2022 as compared to Rs. 346.0867 crores during the period ended March 31, 2022. The company has posted a net profit or (loss) of Rs. 0.8485 crores for the period ended June 30, 2022 as against a net profit or (loss) of Rs. 29.5490 crores for the period ended March 31, 2022. Gross margins declined in Q1FY23 due to pricing pressures in both the API and formulation segments.

First domestic player to launch Adalimumab :

To improve cost efficiencies and improve margin profile, the company is working on process changes, backward integration of intermediates, and increasing the scale of operations.In the API business, the company intends to continue its focus on oncology molecules while reducing its dependence on niche non-onco molecules. Shilpa has set up a dedicated block which includes R&D and production blocks. It intends to complete 6 molecules, 2 in FY23 and 4 in FY24, for the exhibit batches. The company is working on specialised polymers and believes there is enough opportunity to grow in the segment. Management expects phase-1 studies to start by CY22-end and complete them in 9 months. Shilpa has been able to stabilise the product for 1 kL. The molecule will start with the grade market, which has small potential, and then move towards formulations. Shilpa intends to give some time for the business to stabilise before looking at an IPO. Shilpa has largely completed the remediation of the Jadcherla formulations unit. Third-party audits of the plant have also concluded without any data integrity issues. Company is constantly in touch with the USFDA with regular updates. On approval, Shilpa is expected to become the first domestic company to launch high-concentration Adalimumab. Given the studies were conducted in the EU, the company intends to pursue launches in the RoW market. The domestic market size for the molecule is Rs. Certain expenses have been capitalised, which will impact P&L, but they are not significant. Capex: Rs 4 billion was earmarked for the Albumin project, of which Rs 1.2 billion has been utilised. Apart from maintenance, there is no major capex for the formulations plant. The Capex for the API business will depend on capacities and the management expects an expense of  Rs400mn-500mn.

The company does not plan more investments in biologics. Onco and other API segments witnessed one-offs during Q1FY23 on account of Ind-Asu requirements and trading revenues, respectively. We believe performance will remain steady going forward, with the USFDA resolution remaining the key to faster growth. Key upside risks are early resolution of the import alert, high-value launches in formulations, and quick success in biosimilars.

Valuations:

EPS is at Rs. 0.10 for the June quarter as compared to Rs. 3.40 in the March quarter and Rs. 0.2 in the June 2021 quarter. The ROCE and ROE are at 5.58% and 3.35%, respectively. The EBITDA stood at 19.2x while the price to book ratio was at 1.81x. The stock was trading at a P/E ratio of 62.0x. The scrip was at Rs.388 on Thursday, up by 0.90%.

 

 

BHEL Secures Major Power Project Contracts from Adani Group

Bhageria India reported a net profit of Rs. 2.38 cr.

Bhageria India reported a net profit of Rs. 2.38 cr.

The net sales were at Rs 108.12 crore in June 2022, down 4.33% from Rs 113.02 crore in June 2021. The quarterly net profit stood at Rs. 2.38 crore in June 2022, down 81.65% from Rs. 12.96 crore in June 2021. The EBITDA stands at Rs. 11.99 crore in June 2022, down 49.83% from Rs. 23.90 crore in June 2021.

Are retained earnings used effectively?

The company earned revenue of Rs.99.59 Cr from the chemical segment, Rs.8 Cr. from solar power and Rs.0.4 Cr. from other segments for the year ending in March 2021. The EBIT from the chemical segment was Rs. 2.43 Cr., Rs. 3.75 Cr. from the solar power segment and Rs. 0.86 from other. The company incurred a finance cost of Rs. 1.08 cr. and other unallocated expenditure of Rs. 2.38 cr. The surplus current assets suggest that Bhageria Industries has a conservative balance sheet and could probably eliminate its debt without much difficulty. Succinctly put, Bhageria Industries boasts net cash, so it’s fair to say it does not have a heavy debt load.

Any business needs free cash flow to pay off debt; accounting profits just don’t cut it. Bhageria Industries has net cash on the balance sheet, but it is still interesting to look at how well the business converts its earnings before interest and tax (EBIT) to free cash flow, because that will influence both its need for, and its capacity to manage debt. Bhageria Industries created free cash flow of 14% of its EBIT. That level of cash conversion undermines its ability to manage and pay down debt. While it is always sensible to investigate a company’s debt, in this case, Bhageria Industries has 152.4m in net cash and a decent-looking balance sheet. So we are not troubled with Bhageria Industries’s debt use. However, not all investment risk resides on the balance sheet.

Valuations:

EPS is at Rs.0.55 for the June quarter as compared to Rs.4.17 in the March quarter and Rs.2.39 in the June 2021 quarter. The ROCE and ROE are at 19.2% and 14.7%, respectively. The EBITDA stood at 6.48x while the price to book ratio was at 1.46x. The stock was trading at a P/E ratio of 12.3x. The scrip was at Rs.170 on Thursday, up by 0.18%.

 

 

Financial Results for Pokarna LTD.

Financial Results for Pokarna LTD. (Q1 FY2023)

Pokarna Ltd has reported an income of Rs. 240.3884 crores during the period ended June 2022 as compared to Rs. 205.2388 crores during the period ended March 2022. The company has posted a net profit or (loss) of Rs. 28.4906 crores for the period ended June 30, 2022, as against a net profit or (loss) of Rs. 20.1066 crores for the period ended March 31, 2022. The EBITDA stood at Rs. 46.02 crores in March 2022, up 107.58% from Rs. 22.17 crores in March 2021. The margins would have been better but for the forex loss of Rs. 6.82 cr on account of restatement of debt drawn for establishing a new unit, which was offset against the forex gain on exports. The net forex loss charged to the P & L account is Rs. 1.65 cr, reported under other expenses.

Business growth remains strong.

The business environment remains challenging. While sequentially there is an improvement, on an overall basis, business continues to face growth hurdles. The revenue growth remains strong on the back of higher offtake and new product launches. We expect sales momentum to be sustained as new units start ramping up production. The operating margins stood at 25% for the quarter. The focus is on improving the capacity utilisation of new quartz units. Supply chain disruptions, port congestion, container unavailability, and rising shipping costs continue to pose a challenge. The exports to the East Coast, though, have smoothened to an extent. The states of Telangana and Andhra Pradesh are found to be home to some of the best quality quartz raw materials. In addition to private label manufacturing, it is distributed and supplied across the globe under the brand name Quantra. The sourcing of the majority of raw material was from captive quarries, which are home to some of the most sought-after colors. The company’s colour palette includes over 75 varieties of granite sourced from India, Ukraine, Madagascar, and Norway. The deep and entrenched relationship with dealers across key regions of operations

Valuations:

Pokarna EPS stood at Rs. 6.49. The Return on Capital Employed was at 2.39%, whereas the Return on Equity (ROE) was at 0.06%. The EBITDA was at 172x and the P/E ratio was at 52.2x. The price-to-book ratio was recorded at 13.2x and the interest coverage ratio was at 0.33x. The scrip was trading at Rs.550, down by 2.90% on Monday.

Supriya Lifescience Ltd Q1 FY23 Result Updates.

Mold-Tek reported a sale of Rs. 207 crores.

Mold-Tek reported a sale of Rs. 207 crores.

Mold Tek Packaging has reported an almost 80% increase in net profit to Rs 21.71 crore for the June quarter. The total sales were at 207.8 crore, an increase of 55% from the year-earlier period and 16.81% up from Q4 FY22. The profit before tax was Rs. 29 crores and the volume growth was 51.17%. While the inflationary environment continued to impact the margins, the company delivered healthy operating margins of 18% with its focus on IML packs and operational efficiencies across all segments. They have a huge CAPEX of Rs. 125 Cr. planned in FY. 22-23. The EBIDTA was up by 46.84% from June 2021 and 13.59% from Q4 of FY22. The EBIT for the quarter increased by 46.84 % to Rs. 37.3 crore from Rs. 25.40 crores.

Expansion Plans:

As previously stated, the company intends to invest 125 crores in capital expenditures this fiscal year on capacity at its facilities in Hyderabad, Daman, Visakhapatnam, and Kanpur. It has also been decided to set up a second plant in Daman with robotic IML facilities to produce food and FMCG IML containers to meet the growing customer demand in the western region. For the value of a company’s earnings growth, it is very important to consider any dilution of shareholders’ interests. As it happens, Mold-Tek Packaging issued 13% more new shares over the last year. Therefore, each share now receives a smaller portion of the profit.

The company raised equity from QIP and the allottees who have been allotted more than 5% in the QIP are Goldman Sachs Funds—Goldman Sachs India Equity Portfolio (27.61%), Ashoka India Equity Investment Trust PLC (21.24%), Aditya Birla Sun Life Trustee Private Limited A/C (19.30%), ICICI Prudential SmallCap Fund (14.48%) and White Oak India Equity Fund IV (10.62%). Mold-Tek Packaging utilised the net proceeds from the QIP issue for the company’s ongoing and future capital expenditure requirements, working capital requirements, debt repayment, and general corporate purposes.

Mold-Tek Packaging has a weak cash flow relative to earnings, which indicates lower quality earnings, and the dilution means its earnings per share growth is weaker than its profit growth. For the reasons mentioned, we think that an unthinking glance at Mold-Tek Packaging’s statutory profits might make it look better than it is on an underlying level.

Valuation:

The EPS was at Rs. 23.8. for the June quarter, up by 54.82% Q1 from June 2021 and by 17.81% from the Q4 of FY22. The Return on Capital Employed was 22.5%, whereas the Return on Equity (ROE) was 18.2%. The EBITDA was at 24.2x and the P/E ratio was at 43.8x. The price-to-book ratio was 6.62x and the interest coverage ratio was 14.0x. The scrip was trading at Rs.970, down by 0.39% on Monday.

 

Dalmia Bharat Reports Disappointing Q3 Results, Sees Limited Short-Term Growth

JK Cement to report a net profit of Rs. 163 crores.

JK Cement to report a net profit of Rs. 163 crores.

The company has reported sales of Rs. 2270 crores during the period ended June 2022, as compared to Rs. 2351 crores during the period ended March 2022. The company has posted a net profit of Rs. 163 crores for the period ended June 30, 2022, as against a net profit of Rs. 201 crores for the period ended March 31, 2022. The company has an EPS of Rs. 21.06 for the period ended June 30, 2022 as compared to Rs. 26.03 for the period ended March 31, 2022. The margins are at 17.7% in Q1 FY23 versus 23.5% in Q1 FY22.

Margin expansion at a low cost:

Grey cement volume fell 10% QoQ to 0.31 Cr. MT. The total sales stood at 86% vs. 75% YoY. The volume of putty increased 38% year on year to 5 lakhs. With a QoQ increase in the sales share of putty, blended Net Sales Realization (NSR) firmed up 6% QoQ and rose 7% YOY. The total Opex was up a modest 4% QoQ, mainly on a loss in grey cement and on lower fuel inflation. Thus, blended unitary EBITDA rebounded 16% QoQ to INR 1,101 per MT. The margin for both grey and white segments expanded by 100/250bps QoQ to 17/20% and 20%, respectively, implying EBITDA of INR 900/MT. The UAE subsidiary’s revenue went up 28% YoY to INR 100Cr. As JK Cement split the useful life of its cement power plants into 15-20 year periods, depreciation expense went up 16% QoQ.

 In Q1FY23, healthy pricing recovery in the northern regions, subdued fuel cost inflation, and low cost inventory benefits increased blended unitary EBITDA by 16% QoQ to INR 1,101 per MT as margins in both the grey and putty segments rebounded. While consolidated revenue rose 32% year over year, EBITDA came in flat. JKCE’s central expansion of 4 million MT is on track by Q4FY23. The company plans to further add 6 million MT of grey cement capacity in the central and northern regions by the end of FY25 to brace its distribution reach.

Valuations:

 The stock P/E for JK cement is at 32.5x. With a five-year P/E of 24.8x, the EPS stood at Rs. 85.1. The return on capital employed was 16.6% and the return on equity was 17.4%. The EBITDA was recorded at 15.4x. The ROA was at 6.57% and the price to book ratio was at 4.90x. The scrip closed at Rs. 2736, up by 1.36%.

Equityright Manorama Site visit

Manorama Industries. Strong Growth potential.

Manorama Industries. Strong Growth potential. Target Price Achieved

Manorama Industries.

With the cocoa seeds on the brink of deficiency, substitute products are an emerging segment. Cocoa Butter Equivalent (CBE) is a quality substitute to cocoa in chocolates. Manorama is a pioneer in the same. Incorporated in 2005,Manorama Industries initially was engaged in the supply of exotic and specialty oils. Their product is extracted from Sal seeds, Mango Kernel, Shea nuts, Kokum kernel and other naturally procured raw material. Manorama has expanded into manufacturing, processing and supply of extracting oil, butter and proteins.

PAT recorded a robust growth of 83.98% YoY at Rs 19.06 crores FY19 as against Rs 10.36 crores FY18. EBITDA margin witnessed YoY increase of 72.12% and stood at Rs 31.86 crores. Revenue declined by 53.24% at Rs 102.87 crores FY19. The bottom line figures were maintained with the expenses being curbed at 63.50% FY19.  The short term borrowings increased by Rs 17.81 crores FY18 were utilized in the purchase of inventories that stood at Rs 18.03 crores. The contribution of manufacturing segment to revenue stood at 27.83%. The maximum contribution to the revenue segment was of 98% by Sal based products.

Ratios FY15 FY16 FY17 FY18 FY19
PAT (in crores) 0.94 1.08 1.38 10.36 19.06
Sales (in crores) 132.53 131.04 145.48 219.38 102.87
EBITDA (in crores) 4.32 4.31 3.67 18.51 31.86
EBITDA Margin (%) 3.26 3.29 2.52 8.41 30.97
RoA (%) 4.97 5.86 6.44 29.87 21.30
RoE (%) 53.56 55.10 63.89 213.39 204.18
Net worth (in crores) 9.64 13 14.37 24.72 103.91

 

Business Overview:

Cocoa Butter Equivalent (CBE) :

They are the largest Indian manufacturers of Sal/Mango based specialty fat CBE(Cocoa Butter Equivalent) which is an alternative to the Cocoa butter utilized in the manufacturing of confectionery and cosmetic products. The extracted exotic products and specialty fats are essential raw materials for cosmetic, confectioneries and health industries due to their properties. Extracted from seeds found in the tribal areas, their main suppliers are the tribal community who consist of over 7.8 million individuals residing in 18000 villages.

Clients :

Along the way Manorama has earned its goodwill with over 4 decades of relationship with global chocolate giants. Their client list consists of Mondelez/Cadbury that contributes about 60% to its total revenue. Along with being the largest manufacturer they are also tagged with being the largest Indian exporter of Sal and Mango based specialty fats & CBEs to the Asian and European markets.

Manufacturing Process :

Tree borne seeds are purchased through the established market village centers. Manorama industries are one point vendor for the tribal. It currently has 18000 collection centers operational. There are two manufacturing processes namely solvent extraction & pre-processing and the second one is refining and fractionation. Solvent and pre-processing has been outsourced to a third party. Whereas, refining and fractionation is carried out at the manufacturing facility in Nagpur. The key source of raw material is sal seeds and mango kernel. The product segment has been bifurcated into mainly 4 parts; personal care, specialty fats, commodities and feeds.

CMP Rs 209
BSE SME Ticker 541974
Face Value Rs 10
Mcap 232.57
52w H/L Rs 219/180
Industry Edible Oil

Shareholding Pattern :

Shareholder No of share-holder Total no of shares  % of share Voting Rights %
Promoter &Promoter Group 3 67,91,203 61.03 61.03
Public 343 43,36,707

 

38.97 38.97
Grand Total 346 1,11,27,910

 

100 100

Raipur Facility :

For improving the efficiency an all integrated facility has been set up in Raipur. The entire process of extraction of Indian exotic fats inclusive of the labor intensive process will be carried out at the Raipur facility .The Capex incurred for installing the machines amounted up to Rs 45.61 crores. The electrical installments expenditure stood at Rs 1.84 crores. The plant is expected to enhance the solvent extraction capacity of Sal by 26% at 33,750 metric tonnes (mt). Manorama has undertaken the decision to shut the Dry Factorization and continue solvent factorization at the new installed facility. Dry factorization has the efficiency of 60% and wet factorization has the efficiency of 90%.  As per the company estimates production capacity is supposed to increase to 11,250 tonnes.

  1. Dry Factorization : The process is carried out by simple cooling which is called crystallization. Executed in over 48 hours it undergoes the process of pressing wherein the liquid Oleine is released. The hard product left is called stearine. it is the main ingredient for CBE component. During the process Stearine gets mixed with the Oleine part which makes the process inefficient. Oleine contains 35% of the Stearine due to which it has go through re-factorisation.
  2. Wet/Solvent Factorization : It is a high investment process that gets completed in about 3- hours. The yield of stearine extraction is higher. The quality of stearine extracted is better as it is completed separated from Oleine and re-factorization is not required. The solvent stearine can be easily blended to manufacture CBE. This curbs its manufacturing cost and makes it more profitable as against dry factorization.

 

 

Group Companies

  • Manorama Resources Pvt Ltd

Incepted in 2009 engaged in the international trade of oil cake, de-oiled cake, various types of oil seeds, wheat, maize,rice, wheat,  raw cotton, etc. Along with these products soy meal, cotton seed meal, rice bran meal, etc. are also being traded on the international market.

  • Manorama Energy Pvt Ltd

Renewable energy projects are undertaken. Focused on green energy initiatives like jatropha farming and industrial production through solar or wind energy. No significant projects has been undertaken as yet.

Industry Overview :

 

Exhibit 1: Retail Consumption of Chocolate confectionary worldwide (000 Metric Tonnes)

retail consumption of choclate

Source: Company, Equity Right

 

Overview on the chocolate market :

  • Confectionery forms a key part of the market in the developed countries. The chocolate we consume is the sweetened product of the cacao seeds that are processed to form solid blocks or paste used as an ingredient in chocolates.
  • The average global consumption growth was recorded over just 2% p.a in the past decade. From FY12-17 the global chocolate market recorded a CAGR of 3%.
  • Mars ranks as the largest manufacturer globally with over 42% of the American confectionery market.
  • European and the American markets have per capita consumption of more than 5 kgs that outweigh the per capita consumption of Asian markets.
  • Japan government has increased to 7%. Along with the advancing economies such as Brazil, Russia, China and specially India are expected to have an annual growth rate of 20%.

 

Exhibit 2: Per Capita Consumption of chocolate confectionary

per capita choclate consumtion

Source: Company, Equity Right

 

Overview on Cocoa :

  • Cocoa being a cash crop is of prime importance to the countries that export and import it. Countries importing it usually exist in regions where the climate does not support cocoa production.
  • Largest producing country by volume is Cote d’Ivoire that accounts for 33% of the global supply. Netherlands stands to the largest processing country by volume that handles almost about 13% of the global grinding process.
  • Average annual production of the cocoa beans is recorded at 4 million metric tonnes. In the past decade the grindings have delivered growth of 1.7% p.a.
  • Demand for Cocoa Beans is estimated to increase at 3% over and above the 5% growth recorded in 2016-17.

 

Exhibit 3: Cocoa Prices

cocoa pricesSource: Company, Equity Right 

 

Demand and Supply in India :

  • Cocoa tree demands about 40-50% shade for cultivation which makes it an intercrop grown primarily in the states of Andhra Pradesh, Tamil Nadu, Karnataka and Kerala.
  • The total area under cultivation in the above mentioned states is a total of 2.47 acres of land.
  • India harvested 17,200 metric tons of cocoa beans as per the data released by Cocoa Organization in 2015-16 which stands to be only 1.1% of the harvest in the Ivory Coast which is the largest cocoa bean producer.
  • In the past half a decade cocoa bean production in India has grown at a CAGR of 3.6%. The total consumption of cocoa beans in FY15-16 stood at 37,000 metric tonnes out of which 57% was imported.
  • Food Safety and Standards Authority Board of India(FSSAI) on 1st June’18 has relaxed the norms for usage of CBE in the production of chocolates. The consumption is likely to be 8,000 tonnes in 2018 which expected to grow to 22,000 tonnes by 2022.
  • It is estimated that the international market of specialty fats and oils will grow to a value of US$ 142.1 Bn by 2026.
  • In line with the growth trajectory the CAGR has been estimated at 6.6% with the forecast data from 2018 to 2026.
  • The specialty oils and fats consist of 0 trans-fat. With the growing heath concerns globally this could be a market driver for the chocolate industry.

 

  • FSSAI Jan’18 circular :

In a circular enforced in Jan’18, 5% CBE produced from Indian exotic fats can be used in manufacturing of chocolates. The relaxation is confined for manufacturers procuring their raw material domestically. Manorama stands to gain the most from the CBE deregulation. It is the only player in the market that has the resources to fulfill the increased demand.

 

 

 

 

  • Import Export Policy :

              As per the new import export policy the new input-output norms for export of cocoa butter equivalents has announced an import exemption of 1.02 MTs of Crude Palm Oil & .10 Mts of Mid Fraction against the export of 1.02 Mts of CBE. Manorama currently has 75% of its imports covered under this norm.

 

Products :

 

  • CBE (Cocoa Butter Equivalent): Used as a low cost alternative to cocoa butter in confectionery. Cocoa butter is originally utilized as a core ingredient in manufacturing chocolates. But due to its depleting reserves the cost of procurement has increased prominently. Therefore the companies are opting for alternatives for curbing their expenses. The global CBE demand is currently 1,80,000 tonnes.
  • CBE is a blended component of sal, mango kernel, shea nuts and palm oil. It improves the stability of the fat phase of chocolate product thereby combating undesired fat.
  • Sal Fat : Sal seeds contain 12-14% fat  with are extracted in the presence of hexane. Sal Oil is extracted using conventional extraction methods. Solvent extraction plant has been de nationalized in major states like Chhattisgarh, Odisha, Madhya Pradesh and Jharkhand. This acts as a catalyst for the private players to expand their business. The market is open pan India and is liberally traded.

 

Exhibit 4: Estimated Sal Production in India (000 tonnes)

Source: Company, Equity Right

 

  • Sal Stearine : Fractionated product of Sal Fat. It is 56-70% of the Sal Fat originally obtained. Its properties make it a harder ingredient than cocoa butter making it an easy alternative for manufacturing chocolates. The global Stearine demand is 90000 tonnes. The current production capacity of Manorama is 3000-4000 tonnes which is approximately 3-4% of the global market share. The facility of Raipur is expected to increase the capacity to 10,000 tonnes which will result in market of 10%.
  • Organic Castor Oil :
  1. Sal Oleine : Sal Oleine is the fractionized part of Sal Fat. The oil is emollient making it useful for cosmetic and skin care products. Sal Oleine is liquid at room temperature. It has 0 transfat and is used in making edible oil.
  2. Mango Butter :
  • Kokum Butter
  1. Sal Butter
  • Meal
  1. Sal Meal
  2. Mango Kernel Meal

 

Exhibit 5: Product wise Revenue

Source: Company, Equity Right

 

Currently the chocolate manufacturing arm of Manorama Industries accounts for 80% of its business. Once the Raipur facility becomes operational the company will shift its focus to the cosmetic segment of the business.

 

 

Clientele base:

Manorama caters to domestic as well as international clients. Their international footprint holds more prominence. Japan, Italy, Malaysia, Indonesia, Singapore, are the major clients of manorama. Its domestic list is limited to three states Maharashtra, Madhya Pradesh and Chhattisgarh. The major brands that they supply to in Europe are Mondelez/Cadbury (60% of revenue), Ferrero (Italy), Unigra (Italy), Walter Rau ( Germany),  Oleva Vegetable and Oils(UK). In Asia the customers are based out of Japan namely Mitsui and Adeka Corporation.  The current buyers approximately consume 25,000 tonnes p.a.

 

Management of Manorama Industries has decided that Agro-Product trading segment of the company is supposed to be discontinued from FY19. The breakup provides the contribution of the manufacturing segment as against the trading segment.

 

 

 

 

 

 

 

 

 

 

Segment wise breakup of revenue and expenses as per the restated financial statements

Revenue from Manufacturing activities (Rs in Crores)

Particulars 2018-19 2017-18
Turnover 101.7 61.2
Other Operating Income 1.2 1.2
Operating Expenses 79.3 46.8
Depreciation and Amortization 0.81 9.4
Operating Profit 22.8 14.8
Other Income 3.2 1.7
Profit before Income tax 26 16.4
Income Tax Expenses 6.9 60
Net Profit 19 10.3

 

Revenue from Trading activities  (Rs in Crores)

Particulars 2018-19 2017-18
Turnover 15.79
Other Operating Income
Operating Expenses 15.84
Depreciation and Amortization
Operating Profit (0.47)
Other Income
Profit before Income tax (0.47)
Income Tax Expenses
Net Profit (0.47)

 

Bifurcation of manufacturing and trading revenue in domestic and export segment (Rs in Crores)

Particulars 2018 2017 2016
Manufacturing Break Up
A. Export revenue 4034.25 3524.64 2736.74
As a % of total manufacturing revenue 65.89 61.77 56.34
B. Domestic Revenue 2088.15 2181.8 2120.96
As a % of total manufacturing revenue 34.11 38.23 43.66
Total Manufacturing Revenue 6,122.40 5706.44 4857.7
As a % of total revenue from operations 27.83 39.23 37.07
Trading Revenue 15790.97 8763.99 8212.48
As a % of total revenue from operations 71.78% 60.24% 62.67
Other Operating revenue 84.46 77.34 33.55
Total Revenue from operations 21977.83 14547.77 13103.74

 

 

 

 

 

 

 

 

Directors of the Company :

  • Mr Ashish Saraf : He is the President of Manorama Industries since January 2005. He expanded the business to foreign markets thereby adding fortune 500 customers in their list. 30 years of worldwide work experience in managing the business feasibly. Has favourable relations with the promoters of the Industries.
  • Mrs Vinita Saraf : Daughter of noted promoter and Executive Director Kedarnath Aggarwal, is equipped with 12 years of experience in the industry. She has her bachelors in commerce from Mount Caramel Girls College Bangalore. She resides on the position of Managing Director and Chairman. She is said to be the guiding force behind the operations of Manorama Industries. She shoulders the responsibility of the overall management along with the daily operations of the company. She holds 36.74% shares of the company. She is involved in the development, design, operation and improvement of systems on daily basis.
  • Mr Kedarnath Aggarwal : Experienced in the senior level capacity in processing, quality control, marketing and company law. Exposure to the food processing industry for the past decade.
  • Mr Gautam Kumar Pal : His academic qualification includes MBA in Production and Marketing along with B.Tech (Chemicals) with a specialization in Oil and Fat Technology. Mr Pal is the Director and Chief Technical Officer and is responsible for the management, production and operation of the products. He has been a part of Manorama Industries for the past 18 years.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Financial Statements

Cash Flow Statements : :(Rs in Crores)

PARTICULARS FY14  FY15  FY16  FY17  FY18  FY19
A) Cash Flow From Operating Activities :
Net Profit before tax 1.24 1.44 1.67 2.05 15.91 25.93
Adjustment for  :
Depreciation 0.61 0.69 0.86 0.82 0.71 0.81
Interest Paid 0.97 2.08 1.22 0.69 1.75 5.11
Interest Income / Other Income -0.9 -0.84 -0.6 -0.87 -1.43 -3.13
Provision for Gratuity expenses 0 0.03 0.03 0.04 0.04 0.08
(Profit)/Loss on Sale of Assets                         –                            –                            –    0 0.24
Operating profit before working capital changes 1.9 3.4 3.19 2.72 17.11 28.81
Changes in Working Capital -1.06 7.72 -1.19 8.92 -25.43 -32.45
Cash generated from operations 0.83 11.12 2 11.64 -8.32 -3.64
Less:- Income Taxes paid  -0.67 -0.72 -0.69 -0.98 -3.55 -5.56
Net cash flow from operating activities 0.16 10.39 1.31 10.66 -11.87 -9.2
B) Cash Flow From Investing Activities :
Net Purchase of Fixed Assets/Capital WIP New Project -0.2 -0.95 -0.93 -0.54 -2.34 -25.5
Investment made/Sold during the year                         –                            –                            –                            –    0.1
Increase/(Decrease) in Long Term Loans and Advances 0.05 -0.02 -0.01 0 -0.1
Interest Income 0.9 0.84 0.6 0.87 1.43 3.13
Net cash flow from investing activities 0.74 -0.14 -0.33 0.33 -0.9 -22.37
C) Cash Flow From Financing Activities :
Proceeds from Issue of Share Capital 0.32 0.06 2.27                         –                            –    60.55
Proceeds from Long Term Loans and Advance 0 0 0 0 0 0.42
Increase/(Decrease) in Short Term Borrowings 0.44 -7.9 1.36 -4.65 17.82 5.67
Increase/(Decrease) in Long Term Borrowings -0.2 0.05 -0.17 -0.09 0.09 0.42
Interest Paid -0.97 -2.08 -1.22 -0.69 -1.75 -5.11
Net cash flow from financing activities -0.41 -9.87 2.23 -5.44 16.16 61.97
Net Increase/(Decrease) In Cash & Cash Equivalents 0.49 0.39 3.21 5.55 3.39 30.4
Cash equivalents at the beginning of the year 6.1 6.59 6.98 10.18 15.74 19.12
Cash equivalents at the end of the year 6.59 6.98 10.18 15.74 19.12 49.53

 

 

 

Standalone Restated Balance Sheet : (Rs in Crores)

PARTICULARS FY14 FY15 FY16 FY17 FY18 FY19
EQUITY AND LIABILITIES
Shareholders’ funds
(a)  Share Capital 1.75 1.76 2.16 2.16 7.55 11.12
(b) Reserves and Surplus 6.9 7.88 10.84 12.21 17.17 92.79
Non-current liabilities
(a) Long-term Borrowings 0.22 0.27 0.09 0 0.09 0.51
(b) Long-term Provisions 0.04 0.06 0.09 0.12 0.15 0.22
Current liabilities
(a) Short-term Borrowings 11.2 3.3 4.66 0.01 17.82 23.5
(b) Trade Payables 0.45 1.3 1.52 7.17 1.03 0.37
(c) Other  Current Liabilities 0.45 1.9 0.64 0.85 0.35 1.4
(d) Short Term Provisions 0.2 0.14 0.23 0.09 2.59 2.29
TOTAL LIABILITIES 21.2 16.6 20.23 22.61 46.76 132.23
ASSETS
Non-Current Assets
(a) Fixed Assets 2.48 2.73 2.8 2.51 3.95 21.84
(b) Non-Current Investments 0.01 0.01 0.01 0.01                              –   0
(c) Deferred Tax Assets (Net) 0.11 0.22 0.35 0.46 0.65 0.6
(d) Long-term Loans & Advances 0.03 0.06 0.06 0.06 0.16 0.34
Current assets
7.61 2.86 5.51 1.9 18.03 37
(b) Trade Receivables 3.16 1 0.38 1.07 1.58 13.98
(c) Cash and Cash Equivalents 6.59 6.98 10.18 15.74 19.12 49.53
(d) Short-term Loans & Advances 1.17 2.73 0.44 0.6 1.09 8.37
(e) Other Current Assets 0.04 0.01 0.5 0.26 2.18 0.55
TOTAL ASSETS 21.2 16.6 20.23 22.61 46.76 132.23

 

 

 

 

 

 

 

Standalone Restated Profit and Loss Account :(Rs in Crores)

Particulars FY14 FY15 FY16 FY17 FY18 FY19
Revenue: Continuing Operations 104.4 132.53 131.04 145.48 219.98 102.87
YoY Growth 26.94% -1.12% 11.02% 51.21% -53.24%
Other Income 0.93 0.9 0.66 0.9 1.91 3.18
Total 105.33 133.44 131.69 146.38 221.89 106.05
YoY Growth 26.69% -1.31% 11.15% 51.58% -52.21%
           
Expenses:
Cost of Material Consumed 10.65 43.69 36.09 29.78 34.4 67
Purchase of Traded Goods 84.18 59.27 74.96 91.22 160.01 0
Change in Inventory -4.89 5.13 -3.39 3.61 -15.22 -19.13
Employees Benefit 1.08 1.83 2.49 2.98 2.99 3.55
Other Expenses 9.68 19.19 17.24 15.12 21.21 22.82
EBITDA 4.62 4.32 4.31 3.67 18.51 31.86
YoY Growth   -6.49% -0.23% -14.85% 404.36% 72.12%
Depreciation & Amortization 0.61 0.69 0.86 0.82 0.71 0.81
EBIT 4.01 3.63 3.45 2.85 17.81 31.05
Finance Charges 2.77 2.19 1.78 0.8 1.9 5.11
EBT 1.24 1.44 1.67 2.05 15.91 25.93
YoY Growth   16.13% 15.97% 22.75% 676.10% 62.98%
Tax Expenses        
Current Tax 0.51 0.61 0.72 0.79 5.74 -7.6
Deferred Tax -0.16 -0.11 -0.13 -0.11 -0.19 0.73
PAT 0.9 0.94 1.08 1.38 10.36 19.06
YoY Growth 4.44% 14.89% 27.78% 650.72% 83.98%

 

Exhibit 6: Trend in Revenue from manufacturing

Source: Company, Equity Right

 

Manorama has decided to shut its trading segment from FY19. The revenue that is generated by the company will be purely through its manufacturing arm. Exhibit 1 is the representation of the growth trajectory for the previous 4 years. The highest growth was recorded in FY19. With the CBE allowance enforced the demand has risen considerably.

 

Exhibit 7: Profit after Tax

Source: Company, Equity Right

 

The PAT has delivered a CAGR of 17% FY19 and stood at Rs 19.06 crores. The 5% CBE allowance for India has increased the demand of the cocoa substitutes. This has resulted in the improved revenue figures and enhanced the bottom line figures.

 

Exhibit 8: Revenue v/s Expenses

Source: Company, Equity Right

 

With the trading activities being discontinued from FY18 the overall revenue has decreased. Though the revenue from manufacturing activities has recorded an increase with the additional allowance of 5% CBE in manufacturing chocolates. The bottom line figures were maintained with the expenses being curbed at 63.50% FY19

 

Exhibit 9: Profit before Tax

Source: Company, Equity Right

 

Even though the trading arm of Manorama has been discontinued the company has delivered robust Profit Before Tax at Rs 25.93 crores FY19. It recorded a YoY increase of 62.98% and delivered a CAGR of 12%.

 

Exhibit 10: EBITDA

Source: Company, Equity Right

 

EBITDA has been recorded at Rs 31.86 crores and delivered YoY growth of 72.12% FY19 as against 404.36% FY18. The growth recorded in FY18 was due to the increase in the CBE allowance of up to 5% in production in confectionery in India.

Exhibit 11: NET CASH FLOW FROM OPERATING ACTIVITIES

Source: Company, Equity Right

 

The cash flow from operating activities stood at Rs (9.2) crores FY19. The major increase was recorded in the interest being paid of Rs 5.11 crores. This was due to the short term borrowings being increased for purchasing more inventory due to the increased demand.The net cash flow from the operating activities was from Rs (11.86) crores FY18. The operating profit before working capital changes was Rs 17.11 crores FY18. It was adjusted by the payment of income tax  of Rs 3.55 crores, increasing inventories by Rs 16.13 crores, increase in trade receivables in Rs 50.91 lakhs, increase in short term loans and advances by 49.29 lakhs.

 

Exhibit 12: NET CASH FLOW FROM INVESTING ACTIVITIES

Source: Company, Equity Right

 

Net cash Utilized for purchasing capital work-in-progress for increased demand increased the net amount invested. Rs 25.5 crores were utilized for doing so. Net Cash utilized in investing activities was Rs 90.36 lakhs during FY17-18. Majorly the funds were used for purchasing fixed assets worth Rs 2.34 crores and an increase in the long term loans and advances of Rs 9.69 lakhs. The investment was however offset with the disposal of non-current investments of Rs 10 lakhs and an interest income of Rs 1.43 crores.

 

Exhibit 13: NET CASH FLOW FROM FINANCING ACTIVITIES

Source: Company, Equity Right

 

Net Cash generated from financing activities stood at Rs 16.15 crores. While, this consisted of the short term borrowings worth Rs 17.81 crores, increase in long term borrowings of Rs 9.08 lakhs and payment of interest and finance charges of Rs 69.25 lakhs.

Investment Rationale :

Manorama Industries is a unique and niche company involved in Cocoa Butter Substitute. Despite separating the trading business from the manufacturing, company has shown exceptional growth in PAT numbers, which grew from Rs. 10.36 Crores in FY18  to Rs 19.06 crores  in FY 19. A healthy growth of 83.97%. Revenue declined due to trading business being separated from the manufacturing, as manufacturing is the primary business with better growth prospects, profit margins and company’s main focus moving forward to which we agree.

As per the quote seeing is believing, we visited the company’s office at Raipur and nearby manufacturing plant. The company has robust management lead by Mr Saraf capable of guiding Manorama to new heights.

However, After the completion of mandatory 2 years interim period, company has a high probability of shifting from BSE SME to BSE main board. This coupled with tripling of capacity due to latest manufacturing plant equipped with wet extraction techniques can project a revenue of Rs 200 to 250 Crores. Due to niche business with no competition in foreseeable future we can give a PE multi of 20X FY21E with target price of 368 Rs per share.

Manorama Industries. Strong Growth potential. Target Price Achieved

NCLT ALLOWS MORE TIME FOR GROUNDED JET AIRWAYS

 

 

Manorama Industries analysis is provided by Equity Right and Equity Right Research Team.

For more details about Manorama Industries, offer details, financial performance and valuations feel free to contact our research team at contact@equityright.com.

Equity Right Research provides IPO recommendations in 3 tiers i.e. subscribe, avoid or neutral.

 

Research Team –

Sr. Research Analyst – Mr Parag Shah. parags@equityright.com

 

Visit us at www.equityright.com Equityright Registered Office: Equity right- 20 Laxmi Narayan , M G Road , Ghatkopar East , Mumbai – 40077. India.Corporate Office:, UGB 26,Ground Floor, Phoenix Paragon Plaza, Phoenix Market City, Kurla(W)-400070.Mumbai 400070 MH India

Telephone: 91 98210 99990. Fax: 91 22 62432190.

Email: contact@equityright.com. Website: www.equityright.com.

SEBI Regulations (Research Advisory), Registration No. – INH000004802

 

 

General Disclaimer: This report is for studying purposes only.

 

Investment / Trading in Financial Markets have its own risks. Sincere efforts have been made to present the right investment / trading perspective. The information contained herein is based on analysis and up on sources that we consider reliable. We, however, do not vouch for the accuracy or the completeness thereof. This material is for personal information and we are not responsible for any profit / loss incurred based upon it & take no responsibility whatsoever for any financial profits or loss which may arise from the recommendations above.

 

 

 

Terms and Conditions:

For more details about Manorama Industries, offer details, financial performance and valuations feel free to contact our research team at contact@equityright.com.

visit us at www.equityright.com

Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. EQUITY RIGHT will not treat recipients as customers by virtue of their receiving this report. Nothing in this report constitutes investment, legal, accounting and tax advice or a representation that any investment or strategy is suitable or appropriate to your specific circumstances.

 

The securities discussed and opinions expressed in this report may not be suitable for all investors, who must make their own investment decisions, based on their own investment objectives, financial positions and needs of specific recipient.

This may not be taken in substitution for the exercise of independent judgment by any recipient. The recipient should independently evaluate the investment risks.

The value and return on investment may vary because of changes in interest rates, foreign exchange rates or any other reason.

 

EQUITY RIGHT accepts no liabilities whatsoever for any loss or damage of any kind arising out of the use of this report. Past performance is not necessarily a guide to future performance. Investors are advised to see the Risk Disclosure Document to understand the risks associated before investing in the securities markets.

Actual results may differ materially from those set forth in projections. Forward-looking statements are not predictions and may be subject to change without notice. Our employees in sales and marketing team, dealers and other professionals may provide oral or written market commentary or trading strategies that reflect opinions that are contrary to the opinions expressed herein, and our proprietary trading and investing businesses may make investment decisions that are inconsistent with the recommendations expressed herein. In reviewing these materials, you should be aware that any or all of the foregoing, among other things, may give rise to real or potential conflicts of interest.

EQUITY RIGHT or its associates might have not received any commission/compensation from the companies mentioned in the report during the period preceding twelve months from the date of this report for services in respect unless specifically mentioned in the disclosure.

EQUITY RIGHT encourages the practice of giving an independent opinion in research report preparation by the analyst and thus strives to minimize the conflict in preparation of the research report. EQUITY RIGHT or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with the preparation of the research report. Accordingly, neither EQUITY RIGHT nor Research Analysts have any material conflict of interest at the time of publication of this report.

EQUITY RIGHT or its associates collectively or its research analyst do not hold any financial interest/beneficial ownership of more than 1% (at the end of the month immediately preceding the date of publication of the research report) in the company covered by Analyst, and has not been engaged in market making activity of the company covered by research analyst.

Since associates of EQUITY RIGHT are engaged in various financial service businesses, they might have financial interests or beneficial ownership in various companies including the subject company/companies mentioned in this report.

It is confirmed that equity Right research analysts do not serve as an officer, director or employee of the companies mentioned in the report. This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject EQUITY RIGHT and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdiction s or to a certain category of investors. Persons in whose possession this document may come are required to inform them of and to observe such restriction.

Have a look at our other IPO note:

METAL SCRAP TRADE CORPORATION LIMITED (MSTC) -IPO NOTE: AVOID

 

Delta Corp's Q2FY24 results updates

Delta Corp – Chances of jackpot for investors increasing

Delta Corp limited incorporate in the year 1990, is the largest and only listed company in India engaged in the casino and gaming industry. The company started out as a...

K.P.I Global Infrastructure Ltd. management interaction

Sky is the Limit” – said Mr. Faruk Patel when asked about the future of renewable energy and the company’s latest foray into solar energy market place. KPI Global Infrastructure...